By Aparna Ganapathy, Director – Medical Genetics and Genomics, Strand LS
Infertility remains one of the most challenging reproductive health concerns worldwide, affecting millions of couples seeking to build families. While advances in fertility treatment have expanded reproductive options, many individuals continue to face uncertainty when conventional medical evaluations fail to explain why conception has not occurred.
Increasingly, scientific research points to genetics as a significant factor influencing reproductive health. Advances in genetic testing are helping clinicians uncover underlying causes of infertility that may remain invisible through routine diagnostic methods, offering greater clarity for patients and healthcare providers alike.
Infertility Remains a Global Reproductive Health Challenge
Infertility is defined as the inability to conceive after 12 months of regular, unprotected intercourse. Globally, it affects approximately one in six couples, making it a widespread health concern.
In India, infertility prevalence is estimated at approximately 8%, although rates can vary considerably depending on geography, healthcare access, socioeconomic conditions, and underlying medical factors.
For many couples, fertility investigations successfully identify common causes such as hormonal imbalances, ovulation disorders, blocked fallopian tubes, or abnormalities in sperm quality. However, medical experts estimate that between 15% and 30% of couples receive a diagnosis of unexplained infertility because standard assessments do not reveal a clear underlying cause.
The absence of a definitive explanation often creates emotional and clinical challenges, potentially delaying treatment decisions and future reproductive planning.
The Genetic Foundation of Human Reproduction
Human reproduction depends on a complex network of genes that regulate the development and function of reproductive organs, hormone production, and the formation of healthy eggs and sperm.
Genetic variations can influence multiple stages of the reproductive process. Changes in specific genes may disrupt reproductive pathways, affecting fertility in ways that are not always detectable through traditional diagnostic approaches such as hormone testing, ultrasound imaging, or semen analysis.
Because these genetic changes occur at the molecular level, they frequently remain hidden unless specialized testing is performed.
Genetic Factors Affecting Male Fertility
In men, infertility may result from genetic abnormalities that interfere with spermatogenesis, the biological process responsible for sperm production.
One well-established example is Klinefelter syndrome, a genetic condition in which a male is born with an additional X chromosome. Instead of the typical XY chromosome pattern, individuals with Klinefelter syndrome have an XXY chromosome arrangement. This additional genetic material can impair the body’s ability to produce sperm effectively, often resulting in significantly reduced or absent sperm production.
Another recognized genetic contributor involves AZF (Azoospermia Factor) microdeletions. These are small missing sections of the Y chromosome, which contains critical genetic instructions required for sperm development.
When portions of the AZF region are absent, sperm production may be severely affected, leading to low sperm counts, poor sperm motility, or complete absence of sperm in semen.
Genetic Causes of Female Infertility
Genetic changes can also affect female reproductive health by influencing ovarian function, egg development, and overall fertility potential.
One important condition is primary ovarian insufficiency, in which ovarian function declines before the age of 40. Certain genetic variations have been associated with this condition, affecting the ovaries’ ability to produce and maintain healthy eggs.
Genes such as FMR1 and BMP15 play critical roles in ovarian development and egg maturation. Alterations in these genes may disrupt normal reproductive processes, potentially reducing egg quantity or quality.
Another significant genetic condition associated with infertility is Turner syndrome. Women with Turner syndrome are born with only one X chromosome rather than the typical two. This chromosomal difference can affect ovarian development, often limiting the ovaries’ ability to produce viable eggs.
Genetics and Early Embryo Development
The influence of genetics extends beyond egg and sperm production.
Successful pregnancy depends on healthy fertilization, embryo development, and implantation. Genetic abnormalities affecting any of these stages can prevent pregnancy from progressing normally.
One of the most frequently observed factors is chromosomal aneuploidy, a condition in which an embryo contains too many or too few chromosomes.
Chromosomal abnormalities typically occur during the formation of eggs or sperm. Because chromosomes carry essential genetic instructions required for development, an incorrect chromosome number can disrupt normal growth.
As a result, affected embryos may fail to develop properly, may not implant successfully in the uterus, or may lead to early pregnancy loss. In some cases, these events occur before a woman is aware that conception has taken place.
The prevalence of chromosomal aneuploidy underscores the importance of genetic balance during the earliest stages of human development.
Why Genetic Testing Is Becoming Increasingly Important
As understanding of reproductive genetics expands, genetic testing is becoming an increasingly valuable component of fertility evaluation.
The diagnostic process often begins with karyotyping, a laboratory test that examines the number and structure of chromosomes. Karyotyping can identify missing, extra, or rearranged chromosomes that may contribute to infertility.
For men, clinicians may additionally recommend testing for Y chromosome microdeletions to identify abnormalities that affect sperm production.
When these conventional genetic tests do not reveal a cause, more advanced approaches may be used. One of the most significant developments in recent years is next-generation sequencing (NGS).
NGS enables simultaneous analysis of numerous fertility-related genes, allowing clinicians to identify subtle genetic variations that cannot be detected through chromosome-level testing alone.
By examining genetic information at a much deeper level, NGS provides additional insight into fertility challenges that may otherwise remain unexplained.
Benefits of Identifying a Genetic Cause
Determining whether infertility has a genetic basis can offer several important benefits.
First, it can provide answers for individuals and couples who have struggled with unexplained infertility despite undergoing extensive medical evaluation.
Second, genetic findings may help healthcare providers make more informed treatment decisions, particularly when assisted reproductive technologies such as in vitro fertilization (IVF) are being considered.
Third, understanding underlying genetic factors can help families assess potential hereditary risks and make informed reproductive decisions for the future.
In many cases, genetic information contributes to a more individualized approach to fertility care, supporting treatment strategies that align more closely with each patient’s unique biological profile.
Toward More Personalized Fertility Care
Infertility is a complex condition influenced by multiple biological, environmental, and medical factors. While no single test can provide every answer, advances in reproductive genetics are transforming how clinicians investigate fertility challenges.
Genetic testing is helping reveal previously hidden causes of infertility, improving diagnostic accuracy and supporting more personalized treatment pathways.
As scientific understanding continues to evolve, integrating genetic testing into fertility evaluation may provide greater clarity for individuals facing unexplained infertility while opening new possibilities for more informed and effective reproductive healthcare.
